20/20 Biolabs Files Investor Presentation for Aug 5, 2026 Webinar

What Happened

• 20/20 Biolabs, Inc. (AIDX) filed a Form 8-K on August 5, 2026 (Item 7.01) to furnish an investor presentation that the company intends to use in an investor webinar the same day.
• The presentation is attached to the filing as Exhibit 99.1 (titled "Investor Presentation, August 2026").

Key Details

• Filing date / webinar date: August 5, 2026.
• Exhibit included: 99.1 — Investor Presentation, August 2026 (also submitted with Inline XBRL cover page data as Exhibit 104).
• The company states the furnishing is not intended to be a Regulation FD or securities-law disclosure obligation and that it does not assume any obligation to update the materials.

Why It Matters

• The 8-K gives investors direct access to the presentation materials the company will use in a public webinar, which may contain operational, strategic, or market updates.
• The company explicitly notes the filing is furnished (not filed) under Regulation FD language and disclaims an obligation to update the materials, so investors should review Exhibit 99.1 and the webinar itself for current detail rather than expecting future amendments.